Bronchiolitis obliterans: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 14: Line 14:
}}
}}
{{SI}}
{{SI}}
{{CMG}}
'''Editor-in-Chief:''' Kaochoy Saechao, MD, MPH


{{EH}}
{{EJ}}


==Overview==
==Overview==
Line 142: Line 142:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WS}}
{{WS}}
{{jb1}}

Revision as of 18:24, 16 July 2010

Bronchiolitis obliterans
DiseasesDB 1704
MeSH D001989

WikiDoc Resources for Bronchiolitis obliterans

Articles

Most recent articles on Bronchiolitis obliterans

Most cited articles on Bronchiolitis obliterans

Review articles on Bronchiolitis obliterans

Articles on Bronchiolitis obliterans in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Bronchiolitis obliterans

Images of Bronchiolitis obliterans

Photos of Bronchiolitis obliterans

Podcasts & MP3s on Bronchiolitis obliterans

Videos on Bronchiolitis obliterans

Evidence Based Medicine

Cochrane Collaboration on Bronchiolitis obliterans

Bandolier on Bronchiolitis obliterans

TRIP on Bronchiolitis obliterans

Clinical Trials

Ongoing Trials on Bronchiolitis obliterans at Clinical Trials.gov

Trial results on Bronchiolitis obliterans

Clinical Trials on Bronchiolitis obliterans at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Bronchiolitis obliterans

NICE Guidance on Bronchiolitis obliterans

NHS PRODIGY Guidance

FDA on Bronchiolitis obliterans

CDC on Bronchiolitis obliterans

Books

Books on Bronchiolitis obliterans

News

Bronchiolitis obliterans in the news

Be alerted to news on Bronchiolitis obliterans

News trends on Bronchiolitis obliterans

Commentary

Blogs on Bronchiolitis obliterans

Definitions

Definitions of Bronchiolitis obliterans

Patient Resources / Community

Patient resources on Bronchiolitis obliterans

Discussion groups on Bronchiolitis obliterans

Patient Handouts on Bronchiolitis obliterans

Directions to Hospitals Treating Bronchiolitis obliterans

Risk calculators and risk factors for Bronchiolitis obliterans

Healthcare Provider Resources

Symptoms of Bronchiolitis obliterans

Causes & Risk Factors for Bronchiolitis obliterans

Diagnostic studies for Bronchiolitis obliterans

Treatment of Bronchiolitis obliterans

Continuing Medical Education (CME)

CME Programs on Bronchiolitis obliterans

International

Bronchiolitis obliterans en Espanol

Bronchiolitis obliterans en Francais

Business

Bronchiolitis obliterans in the Marketplace

Patents on Bronchiolitis obliterans

Experimental / Informatics

List of terms related to Bronchiolitis obliterans

Editor-in-Chief: Kaochoy Saechao, MD, MPH

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Bronchiolitis obliterans, or Constrictive bronchiolitis, one form of which is called Popcorn Workers' Lung or popcorn lung, is a rare disease of the lungs in which the bronchioles are plugged with granulation tissue. It is a rare and life-threatening form of fixed obstructive lung disease. Because of similar names, it is often confused with bronchiolitis obliterans organizing pneumonia (BOOP), a completely different pulmonary disorder. Rare cases of Graft vs. Host disease (GVH) can manifest in Bone Marrow Transplant (BMT) patients as BOOP.

Bronchiolitis means inflammation of the bronchioles.

Obliterans refers to the fact that the inflammation of the bronchioles partially obliterates the airways.

Etiology

Bronchiolitis obliterans has many possible causes, including: collagen vascular disease, transplant rejection in organ transplant patients, viral infection (RSV, adenovirus, PCP, HIV, CMV), drug reaction, aspiration and complications of prematurity (bronchopulmonary dysplasia), and exposure to toxic fumes, including: diacetyl, sulfur dioxide, nitrogen dioxide, ammonia, chlorine, thionyl chloride, methyl isocyanate, hydrogen fluoride, hydrogen bromide, hydrogen chloride, hydrogen sulfide, phosgene, polyamide-amine dyes, and ozone. Additionally, the disorder may be idiopathic (without known cause). Template:Ref labelTemplate:Ref labelTemplate:Ref label

Presentation

Bronchiolitis obliterans is a lung disease characterized by fixed airway obstruction. Inflammation and scarring occur in the airways of the lung, resulting in severe shortness of breath and dry cough.

Standard lung capacity is normally around 80% lung usage. Bronchiolitis obliterans reduces this to 16% to 21%.

Symptoms include:

  • dry cough
  • shortness of breath
  • wheezing

The symptoms can start gradually, or severe symptoms can occur suddenly. Template:Ref label

Diagnosis

Bronchiolitis obliterans is often misdiagnosed as asthma, bronchitis, emphysema, or pneumonia.

Diagnosis may include the following tests:

  • Chest X-rays tests.
  • Diffusing capacity of the lung (DLCO) tests are usually normal.
  • Spirometry tests show fixed airway obstructions and sometimes restriction.
  • Lung Volume tests may show hyperinflation (excessive air in lungs caused by air trapping).
  • High-resolution computerized tomography scans of the chest at full inspiration and expiration may reveal heterogeneous air trapping on the expiratory view as well as haziness and thickened airway walls.
  • Lung biopsies may reveal evidence of constrictive bronchiolitis obliterans (i.e., severe narrowing or complete obstruction of the small airways). An open lung biopsy, such as by thoracoscopy, is more likely to be diagnostic than a transbronchial biopsy. Special processing, staining, and review of multiple tissue sections may be necessary for a diagnosis]. Template:Ref label

Prognosis/treatment

This disease is irreversible and severe cases often require a lung transplant. Evaluation of interventions to prevent bronchiolitis obliterans relies on early detection of abnormal spirometry results or unusual decreases in repeated measurements.

Industrial inhalants

There is no consensus classification scheme for bronchiolitis subtypes. One author describes four specific subtypes as follows: cellular bronchiolitis, respiratory bronchiolitis, bronchiolitis obliterans and bronchiolitis obliterans with intraluminal polyps (proliferative bronchiolitis obliterans). There are many industrial inhalants that are known to cause bronchiolitis. Template:Ref label

Industrial workers who have presented with bronchiolitis:

Popcorn Workers Lung

In rare instances, bronchiolitis obliterans may be caused by inhalation of airborne diacetyl — a chemical used to produce the butter-like flavoring in many foods such as candy, microwave popcorn and wines. This first came to public attention when eight former employees of the Gilster-Mary Lee popcorn plant in Jasper, Missouri, developed bronchiolitis obliterans. In 2000, the Missouri Department of Health called in NIOSH to make a determination of the cause, and to recommend safety measures. After surveying the plant and each patient's medical history, NIOSH recommended respiratory protection for all workers in microwave popcorn production. Due to this event, bronchiolitis obliterans began to be referred to in the popular media as "Popcorn Lung" or "Popcorn Workers Lung". Template:Ref labelTemplate:Ref labelTemplate:Ref label

One heavy consumer of microwaved popcorn has been diagnosed with this disease, which is the first known case involving a consumer. Template:Ref label

On August 27, 2007, Weaver Popcorn Company of Indianapolis promised to replace the diacetyl butter flavor ingredient in Pop Weaver popcorn with another flavoring.Template:Ref label.

In September 2007, Dr. Cecile Rose, pulmonary specialist at Denver's National Jewish Medical and Research Center, warned federal agencies that consumers, not just flavoring or food factory workers, may be in danger of contracting bronchiolitis obliterans. David Michaels, of the George Washington University School of Public Health, first published Rose's warning letter on his blog. Template:Ref labelTemplate:Ref labelTemplate:Ref label

On September 4, 2007, the Flavor and Extract Manufacturers recommended reduction of diacetyl in butter-like flavorings. The next day ConAgra Foods announced that it would soon remove diacetyl from its popcorn products.Template:Ref label

See also

External links

  • For more information, go to www.popcornfacts.com [2]
  • [3] Questions and Answers about Diacetyl
  • National Institutes of Health: Haz-Map Information on Hazardous Chemicals and Occupational Diseases by Jay A. Brown, M.D., M.P.H. Bronchiolitis obliterans

Sources

  • Brant & Helms. Fundamentals of Diagnostic Radiology LWW, 1999.
  • Webb, et al. High Resolution CT of the Lung. 3rd edition. LWW, 2000.
  • Harber, Philip; Saechao, Kaochoy; & Boomus, Catherine. Diacetyl-induced lung Toxicological Reviews 2006;vol 25(4):261-72.

References

  1. Template:Note labelBrant & Helms (1999). Fundamentals of Diagnostic Radiology.
  2. Template:Note labelWebb; et al. (2000). High Resolution CT of the Lung (3rd Edition ed.).
  3. Template:Note labelCenter for Disease Control (2002). Fixed obstructive lung disease in workers at a microwave popcorn factory (7th Edition ed.).
  4. Template:Note labelNational Institute for Occupational Safety and Health. Preventing lung disease in workers who make or use flavorings, 2004
  5. Template:Note label Colby, T.V. "Bronchiolitis, Pathologic Considerations". Am J Clin Pathology 1998;109:101-9
  6. Template:Note labelNational Institutes of Health. Haz-Map; Information on Hazardous Chemicals and Occupational Diseases by Jay A. Brown, M.D., M.P.H.
  7. Template:Note labelCalifornia Department of Health Services
  8. Template:Note labelE. Neil Schachter. "Popcorn Workers' Lung". New England Journal of Medicine 2002;347(5):360-1.
  9. Template:Note labelDavid Egilman (2007). "Popcorn Workers Lung"
  10. Template:Note label "Doctor warns consumers of popcorn fumes", Marcus Kabel, Associated Press, September 5, 2007, hosted by Yahoo! News, retrieved 2007-09-10.
  11. Template:Note label Letter from Cecile Rose to U.S. Food and Drug Administration, from www.defendingscience.org
  12. Template:Note label David Michaels (2007). Popcorn Lung Coming to Your Kitchen? The FDA Doesn’t Want to Know, a blog post at thepumphandle.wordpress.com
  13. Template:Note labelReuters New Report: FDA to probe popcorn link in man's lung disease.
  14. Template:Note label Weaver Popcorn Company Press Release: "Pop Weaver Introduces First Microwave Popcorn With Flavoring Containing No Diacetyl", 2007-08-27, hosted at PRNewswire.com. Template:PDFlink.
  15. Template:Note label USA Today. ConAgra to drop popcorn chemical linked to lung ailment

Template:SIB

de:Bronchiolitis obliterans


Template:WS